Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.

Lebre MC, Vergunst CE, Choi IY, Aarrass S, Oliveira AS, Wyant T, Horuk R, Reedquist KA, Tak PP.

PLoS One. 2011;6(7):e21772. doi: 10.1371/journal.pone.0021772.

2.

Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.

Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE.

Arthritis Rheum. 2001 May;44(5):1022-32.

3.
5.

Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy women and in women with systemic lupus erythematosus.

Björkander S, Heidari-Hamedani G, Bremme K, Gunnarsson I, Holmlund U.

Scand J Immunol. 2013 Mar;77(3):200-12. doi: 10.1111/sji.12021.

6.

In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.

Rossi R, Lichtner M, De Rosa A, Sauzullo I, Mengoni F, Massetti AP, Mastroianni CM, Vullo V.

Clin Exp Immunol. 2011 Nov;166(2):184-90. doi: 10.1111/j.1365-2249.2011.04409.x.

7.

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP.

Arthritis Rheum. 2008 Jul;58(7):1931-9. doi: 10.1002/art.23591.

8.

Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.

Neumeier M, Bauer S, Brühl H, Eisinger K, Kopp A, Abke S, Walter R, Schäffler A, Buechler C.

Cytokine. 2011 Dec;56(3):573-80. doi: 10.1016/j.cyto.2011.08.017. Erratum in: Cytokine. 2013 Jun;62(3):453.

PMID:
21890375
9.

Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.

Gouwy M, De Buck M, Pörtner N, Opdenakker G, Proost P, Struyf S, Van Damme J.

Eur J Immunol. 2015 Jan;45(1):101-12. doi: 10.1002/eji.201444818.

10.

Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection.

Salentin R, Gemsa D, Sprenger H, Kaufmann A.

J Leukoc Biol. 2003 Aug;74(2):252-9.

PMID:
12885942
11.

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.

Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M.

Blood. 2001 Apr 1;97(7):1920-4.

12.

Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.

Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.

Circulation. 2004 Feb 24;109(7):932-7.

13.

Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis.

Shadidi KR, Thompson KM, Henriksen JE, Natvig JB, Aarvak T.

Scand J Immunol. 2002 Mar;55(3):274-83.

14.

Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.

Proudfoot AE, Buser R, Borlat F, Alouani S, Soler D, Offord RE, Schröder JM, Power CA, Wells TN.

J Biol Chem. 1999 Nov 5;274(45):32478-85.

15.

Chemokine receptor expression in rat adjuvant-induced arthritis.

Haas CS, Martinez RJ, Attia N, Haines GK 3rd, Campbell PL, Koch AE.

Arthritis Rheum. 2005 Dec;52(12):3718-30.

16.

CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.

Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, Iwahashi M, Ueno A, Ohmoto Y, Makino H.

Arthritis Rheum. 2002 Oct;46(10):2578-86.

17.

Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis.

Shahrara S, Amin MA, Woods JM, Haines GK, Koch AE.

Arthritis Rheum. 2003 Dec;48(12):3568-83.

18.

The chemoattraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5.

Santiago B, Galindo M, Rivero M, Brehmer MT, Mateo I, Pablos JL.

Rheumatol Int. 2002 Jul;22(3):107-11.

PMID:
12111085
19.
20.

Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase.

Fujino M, Miura S, Matsuo Y, Tanigawa H, Kawamura A, Saku K.

Atherosclerosis. 2006 Aug;187(2):301-8.

PMID:
16289073
Items per page

Supplemental Content

Support Center